Product Name:Ethyl 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carboxylate

IUPAC Name:ethyl 4-bromo-1,3-dimethyl-1H-pyrazole-5-carboxylate

CAS:5775-89-3
Molecular Formula:C8H11BrN2O2
Purity:95%
Catalog Number:CM313111
Molecular Weight:247.09

Packing Unit Available Stock Price($) Quantity
CM313111-5g in stock ǧǕȦ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:5775-89-3
Molecular Formula:C8H11BrN2O2
Melting Point:-
Smiles Code:O=C(C1=C(Br)C(C)=NN1C)OCC
Density:
Catalog Number:CM313111
Molecular Weight:247.09
Boiling Point:
MDL No:MFCD02253803
Storage:

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Lorlatinib
Pfizer announced longer-term follow-up results of the Phase 3 CROWN study at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. This study aims to evaluate the efficacy and safety of the third-generation anaplastic lymphoma kinase (ALK) inhibitor LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). The analysis showed that compared with the first-generation ALK inhibitors, the risk of disease progression or death in patients treated with lorlatinib continued to decrease by 81%, and the risk of brain metastasis progression was reduced by 94%.

Related Products